Dale A. Sander

Dale A. Sander

Chief Financial Officer, Chief Corporate Development Officer and TreasureratHumacyte· In proxies 2022–2025

Pay in FY2024Humacyte stock +77.8% the same year

Dale A. Sander was paid $704.2K in FY2024 (Dec). Humacyte stock rose 77.8% that year.

Pay$100 in the stock at the end of FY21 → $52
Pay is from the Summary Compensation Table of each Humacyte proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. HumacytePublic company · 4 yr
    • Chief Financial Officer, Chief Corporate Development Officer and Treasurer2022 – Present · 4 yrStock in role -94%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?